Adeva-Andany MM, Carneiro-Freire N. Biochemical composition of the glomerular extracellular matrix in patients with diabetic kidney disease. World J Diabetes 2022; 13(7): 498-520 [PMID: 36051430 DOI: 10.4239/wjd.v13.i7.498]
Corresponding Author of This Article
María M Adeva-Andany, MD, PhD, Consultant Physician-Scientist, Nephrology, Hospital Juan Cardona, Pardo Bazán x/n, Ferrol 15406, Spain. madevaa@yahoo.com
Research Domain of This Article
Medicine, General & Internal
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Diabetes. Jul 15, 2022; 13(7): 498-520 Published online Jul 15, 2022. doi: 10.4239/wjd.v13.i7.498
Table 1 Major components of the glomerular basement membrane and the mesangial matrix in normal human glomeruli
Glomerular basement membrane
Mesangial matrix
Heparan sulfate proteoglycan
Abundant
Abundant
Laminin
Major component
Minor component
Fibronectin
Minor component
Major component
Type I collagen
Absent in most studies
Absent in most studies
Type III collagen
Absent in most studies
Absent in most studies
Type IV collagen
Major component
Present (inconsistent amounts)
Type V collagen
Present
Present
Type VI collagen
Present
Present
Type XVII collagen
Present
Unknown
Type XVIII collagen
Present
Present
Tubulointerstitial nephritis antigen-like-1
Low abundance
High abundance
Nidogen / Entactin
Present
Low abundance
Fibulin-1
Present
Present
Fibrillin-1
Present
Present
Nephronectin
Present
Present
Vitronectin
Absent
Present
Microfibril-associated proteins
Absent
Present
Table 2 Staining characteristics of the mesangial deposits in diabetic kidney diseases, fibronectin-1 nephropathy, and type III collagen glomerulopathy
Periodic acid Schiff
Methenamine silver
Congo red
Specific analysis
Diabetic kidney disease
Positive
Positive
Negative
Unknown material
Fibronectin-1 nephropathy
Positive
Negative
Negative
Fibronectin-1
Type III collagen nephropathy
Negative
Negative
Negative
Type III collagen
Table 3 Type IV collagen-related kidney disease
Gene/location
Protein
Mutation
Risk of progression to end-stage kidney disease
X-linked Alport syndrome
COL4A5/X chromosome
α5 chain of type IV collagen
Hemizygous (males) or heterozygous (females) mutations
Hemizygous: 100%; Heterozygous: 25%
Autosomal recessive Alport syndrome
COL4A4 or COL4A3/2q36-37
α4 and α3 chains of type IV collagen
Biallelic (homozygous or compound heterozygous) mutations
100%
Autosomal dominant Alport syndrome
COL4A4 or/COL4A32q36-37
α4 and α3 chains of type IV collagen
Heterozygous mutations in the α4 or α3 chains
20% in patients with risk factors for progression
Digenic Alport syndrome
Two of the COL4A3-5 genes
Two of the α3-5 chains
Table 4 Different composition of glomerular extracellular matrix (glomerular basement membrane and mesangial matrix) in normal subjects and patients with diabetes
Normal glomeruli
Diabetic kidney disease
Heparan sulfate proteoglycans
GBM and mesangial matrix
Decreased amount
Laminin
Predominantly in the GBM
Inconsistent
Fibronectin-1
Mainly in the mesangial matrix
It varies according to DKD stage
Type I collagen
Inconsistent
No detectable
Type III collagen
Absent
Abundant
Type IV collagen
Abundant in the GBM
Reduced GBM amount
Type V collagen
Similar to type IV collagen
Increased mesangial amount
Type VI collagen
GBM and mesangial matrix
Increased mesangial amount
Citation: Adeva-Andany MM, Carneiro-Freire N. Biochemical composition of the glomerular extracellular matrix in patients with diabetic kidney disease. World J Diabetes 2022; 13(7): 498-520